Opinion | The Pharmaceutical Industry Heads Into Elon Musk’s Wood Chipper
Who needs N.I.H. grants? A lot of red-state universities, for one.
Related Articles
Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2
Cancer-associated thrombosis is a leading cause of mortality. Lucotti et al. uncover the formation of a pro-thrombotic niche in the non-metastatic lung microenvironment that promotes thrombosis…
Pfizer’s investigational candidate combo cuts prostate cancer progression by 49% in phase 1
After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside | After an apparent accidental early release, Pfizer…
ESMO Plenary on the final OS results from the TROPION-Breast01 trial – OncoDaily
ESMO Plenary on the final OS results from the TROPION-Breast01 trial / cancer, ESMO, ESMO Plenary, OncoDaily, Oncology, TROPION-Breast01 trial
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer | NEJM
Neuregulin 1 (NRG1) fusions are recurrent oncogenic drivers found in multiple solid tumors. NRG1 binds to human epidermal growth factor receptor 3 (HER3), leading to…
Program Guide – ASCO Meeting Program Guide
Toni Choueiri , Jae Lyun Lee , Jaime Merchan , Amita Patnaik , Benjamin Garmezy , Alexandra Drakaki , Moshe Ornstein , Bradley McGregor ,…
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers
In this statement, ASCO encourages academic medical centers to change their policies and expectations to enhance and promote the professional fulfillment of academic medical oncologists.…
Comparison of 1-year mortality predictions from vendor-supplied versus academic model for cancer patients
Purpose The Epic End of Life Care Index (EOLCI) predicts 1-year mortality for a general adult population using medical record data. It is deployed at…
Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial – Alzheimer’s Research & Therapy
Background Evidence links lifestyle factors with Alzheimer’s disease (AD). We report the first randomized, controlled clinical trial to determine if intensive lifestyle changes may beneficially…
